Apr 11, 2022, 08:45
Carbiotix (publ) ("Carbiotix" or "Company") announces today that the Company CEO Kristofer Cook has purchased Carbiotix shares for SEK 450,000 between March 25 and April 8 through his holding company Sustainable Holding Sweden AB and has pre-subscribed to purchase a further 550,000 SEK in the proposed rights issue scheduled for the second quarter of 2022. Kristofer Cook has thereby committed to share purchases totaling SEK 1 million before and including the planned rights issue. Kristofer Cook's total holding before the latest acquisition was 2 410 000 shares, corresponding to 19.54 percent. After the acquisition, the holding amounts to 2,448,528 shares, corresponding to approximately 19.85 percent of the voting rights and capital of the Company.
Kristofer Cook, CEO of Carbiotix, comments
"A decision to increase my position in Carbiotix reflects my continued and growing faith in the Company, especially in light of our recent progress moving towards the commercialisation of our first CarbiAXOS product and the interest shown in the market. The 550,000 SEK pre-subscription is part of the SEK 1 million pre-subscribed by Carbiotix management team and Board that was previously communicated.
The Swedish article is available via the following link: Carbiotix sammanfattar aktiviteter under Q1 - positiva framsteg och intresse för CarbiAXOS - Carbiotix (cision.com)
This communication contains forward-looking statements, consisting of subjective assumptions and forecasts for future scenarios. Predictions for the future only apply as of the date they are made and are, by their nature, as is research and development work in the biotechnology segment, associated with risk and uncertainty. With this in mind, the actual outcome may deviate significantly from the scenarios as described in this press release.
For further information:
Kristofer Cook, CEO
Tel: +46 (0)708-796580
Carbiotix AB (CRBX) (www.carbiotix.com) is an award-winning biotechnology company pioneering microbiome healthcare through a range of cost-effective gut health testing services and a portfolio of microbiome modulators covering prebiotic ingredients, medical foods and therapeutics.Go Back